Beacon Securities analyst Russell Stanley has reiterated his “Buy” rating and C$20.00 target on Trulieve Cannabis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results